The reason for CY's highly significant therapeutic superiority to other tested chemotherapeutic agents in conjunction with TLRa is not readily apparent, particularly since two additional alkylating agents, temozolomide and oxaliplatin, proved ineffective (data not shown).
← all excerpts
Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.
1
—
—